In 2024, the trade exchange (includes international purchases and sales) of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) was US$485M.
In 2024, the states with the most international sales in Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were Baja California (US$278M), Jalisco (US$15.9M), Chihuahua (US$9.5M), Tamaulipas (US$6.83M), and Ciudad de México (US$558k).
The states with the most international purchases in 2024 were Baja California (US$96.4M), Ciudad de México (US$44.1M), Nuevo León (US$11.5M), Jalisco (US$9.41M), and Chihuahua (US$6.43M).
In 2024, the main commercial destinations of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were United States (US$290M), Canada (US$9.69M), Poland (US$8.31M), Australia (US$846k), and China (US$622k).
The main commercial origins of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) in 2024 were United States (US$44.7M), Philippines (US$23.8M), Singapore (US$16.5M), Vietnam (US$15M), and Denmark (US$13.6M).
In the global context, the main exporting countries of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) in 2022 were United States (US$3.25B), Ireland (US$1.82B), and Netherlands (US$1.5B). In the same year, the main importing countries of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were United States (US$1.98B), Netherlands (US$1.79B), and Germany (US$1.64B).